Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Advanced Medical Solutions ( (GB:AMS) ) just unveiled an announcement.
Advanced Medical Solutions Group plc announced that Montagu Private Equity LLP has decided not to make an offer for the company, as confirmed by Montagu’s adherence to Rule 2.8 of the City Code on Takeovers and Mergers. The AMS Board expressed satisfaction with the company’s performance and remains confident in its growth strategy, which is expected to drive value creation for shareholders.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer of innovative tissue-healing technology. The company focuses on delivering quality outcomes for patients and value for payers, offering a wide range of surgical products such as tissue adhesives, sutures, haemostats, and internal fixation devices. AMS markets its products under various brands including LiquiBand, RESORBA, and ActivHeal, and operates globally with manufacturing facilities in several countries and R&D hubs in the UK, Ireland, Germany, France, and Israel.
YTD Price Performance: -4.25%
Average Trading Volume: 1,027,369
Technical Sentiment Signal: Buy
Current Market Cap: £392.1M
Learn more about AMS stock on TipRanks’ Stock Analysis page.